Panel rejects Sanofi obesity drug
115232
SILVER SPRING, Maryland  - U.S. regulators should reject a proposed weight-loss pill called Zimulti because of concerns it may increase suicidal thinking and depression, an advisory panel unanimously said on Wednesday.
275903
A U.S. advisory panel  urged the government on Thursday to reject Merck & Co Inc's   latest bid to sell a cholesterol-lowering drug without  a prescription.
765171
Patients who took a Sanofi-Aventis  SA obesity pill in clinical trials were more likely to report  suicidal thoughts or actions, U.S. drug reviewers said in an  analysis released on Monday.
693013
A U.S. judge has granted a request from  Sanofi-Aventis and U.S. partner Bristol-Myers Squibb Co.   to block the sale in the United States of a generic  form of its top selling blood-thinner Plavix, giving a boost to  shares in the French drugmaker on Friday.
223287
The panel said that while Americans could benefit from taking a Merck cholesterol-lowering drug, they should not begin such a regimen without a doctor's advice.
249030
Sanofi-Aventis SA is withdrawing its application to sell obesity drug rimonabant -- its biggest new drug hope -- in the United States, the French drugmaker said on Friday.
696865
Federal health advisers recommended against over-the-counter sales of a cholesterol drug, saying that patients need medical guidance in treating a condition that has no symptoms and may require drugs for life to stay healthy.
398593
U.S. regulators on Friday turned  down AstraZeneca Plc's  AZN.L AZN.N anti-clotting drug  Exanta, following the advice of an advisory panel on which some  members had voiced doubt about the drug's safety and  effectiveness.
482801
A new obesity wonder drug, Acomplia (rimonabant), makes patients lose 10% of their body weight, according to clinical trials carried out by Sanofi-Aventis, the third largest pharmaceutical company in the world.
524641
U.S. regulators should  reject a proposed weight-loss pill called Zimulti because of  concerns it may increase suicidal thinking and depression, an  advisory panel unanimously said on Wednesday.
680868
Sanofi-Aventis's anti-obesity drug Acomplia is facing three generic competitors in India even before it has won full approval from some markets, Les Echos newspaper reported on Thursday.
707710
US medical experts on Wednesday voted unanimously against recommending approval of Inex Pharmaceuticals Corp. and Enzon Pharmaceuticals Inc.
79138
Sanofi-Aventis has withdrawn its   marketing application for its Multaq heart arrhythmia treatment   in the European Union, the world's third-largest drugmaker said   on Thursday.
349821
A panel of US public health experts says the country&#39;s epidemic of childhood obesity threatens to set back the medical advances that have decreased child mortality and extended life spans in the past century.
437844
An FDA advisory panel voted unanimously not to approve Protcer &amp; Gamble&#39;s testosterone patch, Intrinsa, for the female treatment of low sex drive (libido).
186518
A proposed leukemia drug should not receive federal approval, government advisers recommended Wednesday.
14666
A US advisory panel on Friday recommended against approving AstraZeneca&#39;s new stroke prevention medication, Exanta, citing concerns about the drug&#39;s effect on the liver.